๐ฌIn plain words
What the trial is, and whether it could suit you
This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* Age โฅ18
* Admission to the NeuroICU within 36 hours of onset of an acute medical condition.
* Patient or authorized legal representative should be able to provide consent within 36 hours of ICU arrival
* Presence of at least one predictor of critical illness and/or severe brain / spinal cord injury:
* Glasgow Coma Scale GCS \>3 \& \<= 12 at admission
* NIH stroke scale of 6 or greater
* Requirement for ongoing mechanical ventilation
* Requirement for ongoing vasopressor support
* Diagnosis of subarachnoid hemorrhage
* Diagnosis of intracerebral hemorrhage with hematoma volume \> 5 ml
* Diagnosis of moderate-severe traumatic brain injury (GCS \>3 \& \<= 12)
* Refractory Status epilepticus requiring continuous sedative infusions
* Other brain or spinal cord injury or lesion requiring intensive care
Exclusion Criteria:
* Systemic immunosuppression
* Receiving ongoing cancer therapy
* Implanted electrical device (e.g., pacemaker, stimulator)
* Bradycardia on admission (Sustained bradycardia on arrival with a heart rate \< 50 bpm for \>5 minutes)
* Risk of imminent death or limitation of care (e.g., Glasgow Coma Scale of 3, pupillary dilatation)
* Expected ICU stay of less than 72 hours, as determined by attending physician or ICU fellow
* Pregnancy
* COVID-19